SEARCH RESULTS FOR: "Tag: MRNA"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(3)
ARTICLES/BLOGS
2021(12)
2020(49)
2019(1)
CATEGORIES
5-Minute Market Rundown(12)
Analyst Update(4)
Buzz Stocks(22)
Editor's Pick(2)
Intraday Option Activity(11)
Market Recap(6)
Midday Market Check(7)
Opening View(7)
Quantitative Analysis(1)
The Week Ahead(2)

6/10/2021 10:05 AM
Moderna Inc (NASDAQ:MRNA) is back in the spotlight today, after the biotech concern asked the U.S. Food and Drug Administration (FDA) to approve the emergency use of its Covid-19 vaccine mRNA in adole...
6/1/2021 10:30 AM
Moderna Inc (NASDAQ:MRNA) is making headlines yet again today, this time after the biotech name said it has applied for full approval for its Covid-19 vaccine, mRNA, from the U.S. Food and Drug Admin...
5/25/2021 10:30 AM
Moderna Inc (NASDAQ:MRNA) is the second company -- after Pfizer (PFE) -- to develop a Covid-19 vaccine proven to be highly effective in younger age groups. The drugmaker said today that its jab has a ...
5/21/2021 2:06 PM
This past week was a rocky one for Wall Street. On Monday, inflation fears persisted from the previous week's Consumer Price Index (CPI) reading, which weighed heavily on Big Tech, and investors co...
5/21/2021 10:42 AM
Japanese and South Korean regulators officially approved Moderna Inc's (NASDAQ:MRNA) Covid-19 vaccine, alongside the vaccine produced by AstraZeneca (AZN) and Oxford University. Moderna is drumming up...
 
Special Offers from Schaeffer's Trading Partners